chemotherapy: be used after surgery

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be used after surgery 1.00
be used before surgery 0.99
be given after surgery 0.96
is surgery 0.95
be given before surgery 0.95
be done before surgery 0.94
is major surgery 0.91
be given after mastectomy 0.81
be better than kidney transplant 0.79
be treated by doctors 0.76

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.07
Rule weight: 0.13
Evidence weight: 0.66
Similarity weight: 0.79
Evidence: 0.98
¬ Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.35
¬ Remarkable(dialysis, be better than kidney transplant)
0.07
Rule weight: 0.13
Evidence weight: 0.57
Similarity weight: 0.91
Evidence: 0.98
¬ Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.43
¬ Remarkable(mastectomy, is major surgery)
0.04
Rule weight: 0.13
Evidence weight: 0.39
Similarity weight: 0.76
Evidence: 0.98
¬ Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.62
¬ Remarkable(breast cancer, be treated by doctors)
0.01
Rule weight: 0.13
Evidence weight: 0.09
Similarity weight: 0.95
Evidence: 0.98
¬ Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.93
¬ Remarkable(mastectomy, is surgery)

Remarkability from sibling implausibility

0.57
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.95
Evidence: 0.23
Plausible(chemotherapy, be used after surgery) ⋁
Evidence: 0.93
Remarkable(mastectomy, is surgery) ⋁
Evidence: 0.20
¬ Plausible(mastectomy, is surgery)
0.38
Rule weight: 0.60
Evidence weight: 0.69
Similarity weight: 0.91
Evidence: 0.23
Plausible(chemotherapy, be used after surgery) ⋁
Evidence: 0.43
Remarkable(mastectomy, is major surgery) ⋁
Evidence: 0.71
¬ Plausible(mastectomy, is major surgery)
0.38
Rule weight: 0.60
Evidence weight: 0.82
Similarity weight: 0.76
Evidence: 0.23
Plausible(chemotherapy, be used after surgery) ⋁
Evidence: 0.62
Remarkable(breast cancer, be treated by doctors) ⋁
Evidence: 0.60
¬ Plausible(breast cancer, be treated by doctors)
0.33
Rule weight: 0.60
Evidence weight: 0.70
Similarity weight: 0.79
Evidence: 0.23
Plausible(chemotherapy, be used after surgery) ⋁
Evidence: 0.35
Remarkable(dialysis, be better than kidney transplant) ⋁
Evidence: 0.60
¬ Plausible(dialysis, be better than kidney transplant)

Salient implies Plausible

0.17
Rule weight: 0.28
Evidence weight: 0.59
Similarity weight: 1.00
Evidence: 0.23
Plausible(chemotherapy, be used after surgery) ⋁
Evidence: 0.53
¬ Salient(chemotherapy, be used after surgery)

Similarity expansion

0.83
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.99
Evidence: 0.98
Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.92
¬ Remarkable(chemotherapy, be used before surgery)
0.81
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.96
Evidence: 0.98
Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.96
¬ Remarkable(chemotherapy, be given after surgery)
0.80
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.95
Evidence: 0.98
Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.84
¬ Remarkable(chemotherapy, be given before surgery)
0.79
Rule weight: 0.85
Evidence weight: 0.99
Similarity weight: 0.94
Evidence: 0.98
Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery)
0.77
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.96
Evidence: 0.03
Typical(chemotherapy, be used after surgery) ⋁
Evidence: 0.06
¬ Typical(chemotherapy, be given after surgery)
0.68
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.81
Evidence: 0.98
Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.98
¬ Remarkable(chemotherapy, be given after mastectomy)
0.67
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.99
Evidence: 0.03
Typical(chemotherapy, be used after surgery) ⋁
Evidence: 0.21
¬ Typical(chemotherapy, be used before surgery)
0.66
Rule weight: 0.85
Evidence weight: 0.96
Similarity weight: 0.81
Evidence: 0.03
Typical(chemotherapy, be used after surgery) ⋁
Evidence: 0.04
¬ Typical(chemotherapy, be given after mastectomy)
0.65
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.96
Evidence: 0.23
Plausible(chemotherapy, be used after surgery) ⋁
Evidence: 0.27
¬ Plausible(chemotherapy, be given after surgery)
0.61
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.96
Evidence: 0.53
Salient(chemotherapy, be used after surgery) ⋁
Evidence: 0.55
¬ Salient(chemotherapy, be given after surgery)
0.58
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.99
Evidence: 0.53
Salient(chemotherapy, be used after surgery) ⋁
Evidence: 0.65
¬ Salient(chemotherapy, be used before surgery)
0.58
Rule weight: 0.85
Evidence weight: 0.69
Similarity weight: 0.99
Evidence: 0.23
Plausible(chemotherapy, be used after surgery) ⋁
Evidence: 0.40
¬ Plausible(chemotherapy, be used before surgery)
0.55
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.81
Evidence: 0.23
Plausible(chemotherapy, be used after surgery) ⋁
Evidence: 0.26
¬ Plausible(chemotherapy, be given after mastectomy)
0.53
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.95
Evidence: 0.53
Salient(chemotherapy, be used after surgery) ⋁
Evidence: 0.72
¬ Salient(chemotherapy, be given before surgery)
0.51
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.81
Evidence: 0.53
Salient(chemotherapy, be used after surgery) ⋁
Evidence: 0.56
¬ Salient(chemotherapy, be given after mastectomy)
0.48
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.95
Evidence: 0.23
Plausible(chemotherapy, be used after surgery) ⋁
Evidence: 0.53
¬ Plausible(chemotherapy, be given before surgery)
0.47
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.94
Evidence: 0.53
Salient(chemotherapy, be used after surgery) ⋁
Evidence: 0.87
¬ Salient(chemotherapy, be done before surgery)
0.47
Rule weight: 0.85
Evidence weight: 0.58
Similarity weight: 0.95
Evidence: 0.03
Typical(chemotherapy, be used after surgery) ⋁
Evidence: 0.44
¬ Typical(chemotherapy, be given before surgery)
0.35
Rule weight: 0.85
Evidence weight: 0.44
Similarity weight: 0.94
Evidence: 0.23
Plausible(chemotherapy, be used after surgery) ⋁
Evidence: 0.72
¬ Plausible(chemotherapy, be done before surgery)
0.26
Rule weight: 0.85
Evidence weight: 0.32
Similarity weight: 0.94
Evidence: 0.03
Typical(chemotherapy, be used after surgery) ⋁
Evidence: 0.70
¬ Typical(chemotherapy, be done before surgery)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.99
Similarity weight: 1.00
Evidence: 0.53
Salient(chemotherapy, be used after surgery) ⋁
Evidence: 0.03
¬ Typical(chemotherapy, be used after surgery) ⋁
Evidence: 0.98
¬ Remarkable(chemotherapy, be used after surgery)

Typical implies Plausible

0.47
Rule weight: 0.48
Evidence weight: 0.98
Similarity weight: 1.00
Evidence: 0.23
Plausible(chemotherapy, be used after surgery) ⋁
Evidence: 0.03
¬ Typical(chemotherapy, be used after surgery)

Typicality and Rermarkability incompatibility between siblings

0.12
Rule weight: 0.14
Evidence weight: 0.96
Similarity weight: 0.95
Evidence: 0.98
¬ Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.04
¬ Typical(mastectomy, is surgery)
0.04
Rule weight: 0.14
Evidence weight: 0.37
Similarity weight: 0.76
Evidence: 0.98
¬ Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.65
¬ Typical(breast cancer, be treated by doctors)
0.03
Rule weight: 0.14
Evidence weight: 0.26
Similarity weight: 0.79
Evidence: 0.98
¬ Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.75
¬ Typical(dialysis, be better than kidney transplant)
0.02
Rule weight: 0.14
Evidence weight: 0.20
Similarity weight: 0.91
Evidence: 0.98
¬ Remarkable(chemotherapy, be used after surgery) ⋁
Evidence: 0.81
¬ Typical(mastectomy, is major surgery)